-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a cross-sectional study, researchers found an association between type 2 diabetes (T2DM) and smaller bone area and higher total hip bone mineral density (BMD)
diabetes
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
Among the three cohorts, the Swedish Mammography Cohort Clinical Study (SMCC; n=1060), the Prospective Investigation of the Vascular System of the Elderly in Uppsala (PIVUS; n=483) and the Uppsala Adult Male Longitudinal Study In the study (ULSAM; n=203), the researchers repeatedly assessed the subjects’ T2DM status and the total hip area measured by the dual-energy X-ray bone densitometer (DXA), as well as the average BMD over an 8-year period
Blood vessel
Changes in total hip bone area and bone density between baseline, follow-up, and evaluation
After meta-analysis, compared with non-T2DM patients, the total hip bone area change in T2DM patients was reduced by 0.
It can be seen that compared with non-T2DM patients, new-onset T2DM patients have a lower degree of expansion of the total hip area
Compared with non-T2DM patients, new-onset T2DM patients have a lower degree of expansion of the total hip bone area
Original source:
Original source:Adam Mitchell.
Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women
in this message